Profiled support vector machines for antisense oligonucleotide efficacy prediction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Profiled support vector machines for antisense oligonucleotide efficacy prediction ; volume:5 ; number:1 ; day:22 ; month:9 ; year:2004 ; pages:1-9 ; date:12.2004
BMC bioinformatics ; 5, Heft 1 (22.9.2004), 1-9, 12.2004
- Urheber
-
Camps-Valls, Gustavo
- Beteiligte Personen und Organisationen
-
Chalk, Alistair M.
Serrano-López, Antonio J.
Martín-Guerrero, José D.
Sonnhammer, Erik LL
SpringerLink (Online service)
- DOI
-
10.1186/1471-2105-5-135
- URN
-
urn:nbn:de:1111-2016021615276
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Camps-Valls, Gustavo
- Chalk, Alistair M.
- Serrano-López, Antonio J.
- Martín-Guerrero, José D.
- Sonnhammer, Erik LL
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nonviral delivery systems for antisense oligonucleotide therapeutics
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Accessing Therapeutically‐Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical Ligation
Accessing Therapeutically‐Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical Ligation
Support vector machines (8.6.2011)
Parallel Support Vector Machines
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nonviral delivery systems for antisense oligonucleotide therapeutics
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Accessing Therapeutically‐Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical Ligation
Accessing Therapeutically‐Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical Ligation
Support vector machines (8.6.2011)
Parallel Support Vector Machines
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nonviral delivery systems for antisense oligonucleotide therapeutics
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Accessing Therapeutically‐Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical Ligation
Accessing Therapeutically‐Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical Ligation
Support vector machines (8.6.2011)